Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) is expected to be announcing its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share for the quarter.
Rapport Therapeutics Stock Down 11.0 %
Rapport Therapeutics stock opened at $11.78 on Wednesday. Rapport Therapeutics has a 52 week low of $11.43 and a 52 week high of $29.74. The stock has a 50-day moving average price of $15.86 and a 200 day moving average price of $19.76.
About Rapport Therapeutics
See Also
- Five stocks we like better than Rapport Therapeutics
- How to buy stock: A step-by-step guide for beginners
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Are Penny Stocks a Good Fit for Your Portfolio?
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Rapport Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapport Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
